ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 668296 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 668296; 2) Community: the network communities that were significantly associated with the response to NSC 668296; 3) Molecule: the relationships between components within communities and NSC 668296; 4) MDR: the compounds that were significantly associated with the NSC 668296.

NSC Compound Enrichment Correlation
NSC 113951 6-Bromotoyocamycin 0.0430277102950697 0.37819876
NSC 127755 Benzenesulfonyl fluoride, 3-chloro-4-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]butyl]-, monoethanesulfonate (9CI) 0.0430277102950697 0.42595895
NSC 13300 Null 0.0430277102950697 0.16376828
NSC 194618 Benz[a]anthracene-7,12-dione, 1,8-dihydroxy-3-methyl- (7CI, 8CI, 9CI) 0.0430277102950697 0.43134551
NSC 251805 Butanedioic acid, 2-bromo-3-fluoro-, dimethyl ester 0.0430277102950697 0.39925001
NSC 255105 GELDANAMYCIN ANALOG 0.0430277102950697 0.20994838
NSC 294526 Null 0.0430277102950697 0.50056286
NSC 330500 Macbecin II 0.0430277102950697 0.17327269
NSC 354671 1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(2- thiazolyl)ethylidene]hydrazide 0.0430277102950697 0.34669265
NSC 363812 Tetraplatin 0.0430277102950697 0.52416606
Total:119  Current:114    [First] [Prev] [Next] [Last]